For research use only. Not for therapeutic Use.
Cefmetazole（Cat No.:R009673）is a broad-spectrum, semisynthetic cephalosporin antibiotic used to treat bacterial infections. It acts by inhibiting bacterial cell wall synthesis, making it effective against a wide range of Gram-positive and Gram-negative pathogens. Cefmetazole is commonly used in the treatment of urinary tract infections, respiratory infections, and skin infections, among others. It is administered parenterally, typically in hospital settings. With its stability against beta-lactamase enzymes, it offers a reliable option for combating resistant strains. However, proper dosage and monitoring are essential to prevent adverse effects like allergic reactions or gastrointestinal disturbances.
| Catalog Number | R009673 |
| CAS Number | 56796-20-4 |
| Synonyms | (6R,7S)-7-[[2-[(Cyanomethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl?-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene?-2-carboxylic Acid; SKF 83088; U 72791; U 72791a; |
| Molecular Formula | C15H17N7O5S3 |
| Purity | ≥95% |
| Storage | -20°C |
| IUPAC Name | (6R,7S)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
| InChI | InChI=1S/C15H17N7O5S3/c1-21-14(18-19-20-21)30-6-8-5-29-13-15(27-2,17-9(23)7-28-4-3-16)12(26)22(13)10(8)11(24)25/h13H,4-7H2,1-2H3,(H,17,23)(H,24,25)/t13-,15+/m1/s1 |
| InChIKey | SNBUBQHDYVFSQF-HIFRSBDPSA-N |
| SMILES | CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)O |
| Reference | Georgopapadakou, N. H. /Mechanisms of Action of Cephalosporin 3/’-quinolone Esters, Carbamates, and Tertiary Amines in Escherichia Coli./ American Society for Microbiology 37.3 (1992): 559-65. Antimicrobial Agents and Chemotherapy. Web. 21 Aug. 2012.</span></p> |
